You are here

Pharmaceuticals and Healthcare

The business of vital innovation

Share

The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.

Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.

Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.

Recent Experience

Achilles Vaccines

assisting leading Italian vaccine-developer Achilles Vaccines on various projects, including the creation of a platform for streamlining the research and development of new vaccines (including against COVID-19) and the start of a collaboration with vAMRes Lab at Toscana Life Sciences (TLS) Foundation (based in Siena, Italy) on a research project for the development of human monoclonal antibodies against COVID-19, with the aim of using them for prophylactic/therapeutic purposes and as molecular baits for the discovery of vaccine antigens. We also advised on Italian and German finance, IP and regulatory aspects of its EUR 46 million venture loan financing from EMF EU Malaria Fund (a fund linked to EIB)

Abbvie Inc.

Advising Abbvie Inc., on the EU merger control aspects of its US$63 billion acquisition of Allergan

Sterling Pharma Solutions

Advising Sterling Pharma Solutions on its disposal of a UK based pharmaceutical manufacturing business by way of auction sale to GHO Capital

Abcam Plc

Advising Abcam on its acquisition of Expedeon AG's proteomics and immunology business for €120m

Lupin Limited

Advising Lupin, on the sale of its entire stake in its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., Ltd. (Kyowa), to Unison Capital for JPY 57.4 billion (c.US$525 million)

Strides Pharma Science Limited

Advising Strides Pharma Science Limited, an Indian listed pharmaceuticals company, on the AU$394 million sale of its entire Australian business, including Arrow Pharmaceuticals, to Arrotex

Insights and updates

6th October 2022
In the area of patent law, clarity is king. Where precision of language is essential...
19th August 2022
On 18 August 2022, the Commonwealth Government released draft legislation proposing five-fold increases in the...
25th March 2022
Last week, a Full Court of the Federal Court of Australia handed down two unanimous...
18th November 2021
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the...

Related news and deals

18 November 2022

Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询

08 November 2022

Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务

10 October 2022

Herbert Smith Freehills advises sponsors on Jenscare's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为健世科技香港上市提供法律服务

01 September 2022

Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务